Body composition and plasma total‐tau, neurofilament light chain, and amyloid‐β: A population‐based study

Abstract A higher body mass at older age has been linked to a lower risk of dementia. This unexpected trend may be explained by age‐related lean mass depletion, or methodological issues such as the long preclinical phase of dementia or competing risks. Focusing on preclinical markers of dementia may...

Full description

Bibliographic Details
Main Authors: Tosca O. E. deCrom, Mohsen Ghanbari, Trudy Voortman, M. Arfan Ikram
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Subjects:
Online Access:https://doi.org/10.1002/dad2.12519
_version_ 1797242582681518080
author Tosca O. E. deCrom
Mohsen Ghanbari
Trudy Voortman
M. Arfan Ikram
author_facet Tosca O. E. deCrom
Mohsen Ghanbari
Trudy Voortman
M. Arfan Ikram
author_sort Tosca O. E. deCrom
collection DOAJ
description Abstract A higher body mass at older age has been linked to a lower risk of dementia. This unexpected trend may be explained by age‐related lean mass depletion, or methodological issues such as the long preclinical phase of dementia or competing risks. Focusing on preclinical markers of dementia may overcome these issues. Between 2002 and 2005, body composition and plasma total‐tau, neurofilament light chain (NfL), amyloid‐β40, and amyloid‐β42 were measured in 3408 dementia‐free participants from the population‐based Rotterdam Study. The cross‐sectional associations between body composition and plasma markers were determined using linear regression models. Whole body and fat mass, but not lean mass, were positively associated with total‐tau, while all these measures were inversely associated with NfL. Apart from an inverse association between lean mass and amyloid‐β40, body composition measures were not associated with plasma amyloid‐β. Our findings suggest distinct effects of body composition on neurodegeneration.
first_indexed 2024-04-24T18:41:31Z
format Article
id doaj.art-edee958247fe4f56aa8c1d68d54fae4f
institution Directory Open Access Journal
issn 2352-8729
language English
last_indexed 2024-04-24T18:41:31Z
publishDate 2024-01-01
publisher Wiley
record_format Article
series Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
spelling doaj.art-edee958247fe4f56aa8c1d68d54fae4f2024-03-27T13:14:40ZengWileyAlzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring2352-87292024-01-01161n/an/a10.1002/dad2.12519Body composition and plasma total‐tau, neurofilament light chain, and amyloid‐β: A population‐based studyTosca O. E. deCrom0Mohsen Ghanbari1Trudy Voortman2M. Arfan Ikram3Department of Epidemiology Erasmus MC University Medical Center Rotterdam the NetherlandsDepartment of Epidemiology Erasmus MC University Medical Center Rotterdam the NetherlandsDepartment of Epidemiology Erasmus MC University Medical Center Rotterdam the NetherlandsDepartment of Epidemiology Erasmus MC University Medical Center Rotterdam the NetherlandsAbstract A higher body mass at older age has been linked to a lower risk of dementia. This unexpected trend may be explained by age‐related lean mass depletion, or methodological issues such as the long preclinical phase of dementia or competing risks. Focusing on preclinical markers of dementia may overcome these issues. Between 2002 and 2005, body composition and plasma total‐tau, neurofilament light chain (NfL), amyloid‐β40, and amyloid‐β42 were measured in 3408 dementia‐free participants from the population‐based Rotterdam Study. The cross‐sectional associations between body composition and plasma markers were determined using linear regression models. Whole body and fat mass, but not lean mass, were positively associated with total‐tau, while all these measures were inversely associated with NfL. Apart from an inverse association between lean mass and amyloid‐β40, body composition measures were not associated with plasma amyloid‐β. Our findings suggest distinct effects of body composition on neurodegeneration.https://doi.org/10.1002/dad2.12519adiposityamyloiddementialean massneurofilament light chaintau
spellingShingle Tosca O. E. deCrom
Mohsen Ghanbari
Trudy Voortman
M. Arfan Ikram
Body composition and plasma total‐tau, neurofilament light chain, and amyloid‐β: A population‐based study
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
adiposity
amyloid
dementia
lean mass
neurofilament light chain
tau
title Body composition and plasma total‐tau, neurofilament light chain, and amyloid‐β: A population‐based study
title_full Body composition and plasma total‐tau, neurofilament light chain, and amyloid‐β: A population‐based study
title_fullStr Body composition and plasma total‐tau, neurofilament light chain, and amyloid‐β: A population‐based study
title_full_unstemmed Body composition and plasma total‐tau, neurofilament light chain, and amyloid‐β: A population‐based study
title_short Body composition and plasma total‐tau, neurofilament light chain, and amyloid‐β: A population‐based study
title_sort body composition and plasma total tau neurofilament light chain and amyloid β a population based study
topic adiposity
amyloid
dementia
lean mass
neurofilament light chain
tau
url https://doi.org/10.1002/dad2.12519
work_keys_str_mv AT toscaoedecrom bodycompositionandplasmatotaltauneurofilamentlightchainandamyloidbapopulationbasedstudy
AT mohsenghanbari bodycompositionandplasmatotaltauneurofilamentlightchainandamyloidbapopulationbasedstudy
AT trudyvoortman bodycompositionandplasmatotaltauneurofilamentlightchainandamyloidbapopulationbasedstudy
AT marfanikram bodycompositionandplasmatotaltauneurofilamentlightchainandamyloidbapopulationbasedstudy